Search
for
Sort by
Research 751–780 of 1000+
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
- Role of -catenin in Epidermal Stem Cell Expansion, Lineage Selection, and Cancer
- Apoptosis and cutaneous biology
- Application of multiphoton microscopy in dermatological studies: A mini-review
- Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate
- New insights into the functions of Cox-2 in skin and esophageal malignancies
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- Wnt signaling: the good and the bad
- Hair follicles, their disorders and their opportunities
- Cutaneous Manifestations of Eating Disorders
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Cicatricial (Scarring) Alopecias
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Evidence-based approach to cutaneous hyperandrogenism in women
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Novel cosmeceuticals from plants—An industry guided review
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Scalp melanoma: Distinctive high risk clinical and histological features
- Acquired scalp alopecia. Part II: A review
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- MOUSE MODELS FOR THE STUDY OF HUMAN HAIR LOSS
- Treatment options for alopecia: an update, looking to the future
- Nobiletin-loaded composite penetration enhancer vesicles restore the normal miRNA expression and the chief defence antioxidant levels in skin cancer
- Androgens in women
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area